Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free PILL Stock Alerts $6.68 -0.22 (-3.19%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy2.65Holdings in PILL have an aggregate rating of Moderate Buy based on 297 analyst ratings issued in the past year covering 40 companies (84.9% of the portfolio).PILL Aggregate Price Target$11.1466.70% UpsideHigh Prediction$14.16Average Prediction$11.14Low Prediction$8.00Holdings in PILL have an aggregate price target of $11.14 and a range of $8.00 to $14.16 covering 40 companies (84.9% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 PILL Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.58%ITCIIntra-Cellular Therapies$64.96-0.9%5 of 5 stars2.90$90.17 38.8%10Earnings ReportAnalyst Revision4.54%MRKMerck & Co., Inc.$130.06-0.1%5 of 5 stars2.58$131.33 1.0%124.36%PRGOPerrigo$30.71-1.0%5 of 5 stars3.00$40.67 32.4%3Gap Down4.28%OGNOrganon & Co.$20.42-0.4%5 of 5 stars2.50$22.60 10.7%4Ex-Dividend4.23%CTLTCatalent$55.81-0.3%3 of 5 stars2.15$52.46 -6.0%13Earnings ReportAnalyst ForecastShort Interest ↓4.15%AXSMAxsome Therapeutics$72.50-1.6%4 of 5 stars2.92$121.92 68.2%13Analyst Revision4.08%LLYEli Lilly and Company$760.00-1.5%5 of 5 stars2.84$757.95 -0.3%19Earnings ReportDividend AnnouncementShort Interest ↓4.01%VTRSViatris$11.16-0.5%1 of 5 stars1.33$11.00 -1.4%3Earnings ReportDividend Announcement3.98%PFEPfizer$28.01-0.6%5 of 5 stars2.40$35.86 28.0%153.97%RPRXRoyalty Pharma$28.09+0.4%5 of 5 stars3.00$46.75 66.4%4Earnings ReportAnalyst Downgrade3.94%JNJJohnson & Johnson$149.91+0.0%5 of 5 stars2.46$175.86 17.3%13Short Interest ↑Analyst Revision3.92%JAZZJazz Pharmaceuticals$109.63-3.1%5 of 5 stars2.85$192.75 75.8%133.61%ZTSZoetis$169.04+0.5%5 of 5 stars3.00$211.75 25.3%7Short Interest ↑3.56%BMYBristol-Myers Squibb$44.94+0.4%5 of 5 stars2.11$60.00 33.5%19Short Interest ↓Analyst Revision3.40%ELANElanco Animal Health$17.00-1.2%3 of 5 stars2.57$17.29 1.7%7Earnings ReportShort Interest ↓Analyst Revision2.92%CORTCorcept Therapeutics$27.04+1.7%5 of 5 stars3.00$40.10 48.3%4Short Interest ↓2.16%ARVNArvinas$31.44-1.6%2 of 5 stars2.88$61.13 94.4%16Earnings ReportAnalyst Revision1.87%AMPHAmphastar Pharmaceuticals$42.21-0.5%5 of 5 stars2.50$66.00 56.4%41.83%SAVACassava Sciences$20.23-4.2%3 of 5 stars3.00$124.00 513.0%11.65%EYPTEyePoint Pharmaceuticals$12.09-4.6%2 of 5 stars3.00$34.14 182.4%7Analyst Revision1.49%TARSTarsus Pharmaceuticals$37.00+8.7%3 of 5 stars2.88$49.88 34.8%8Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage1.27%PBHPrestige Consumer Healthcare$70.39+0.1%4 of 5 stars2.50$110.00 56.3%2Upcoming EarningsPositive News1.05%PCRXPacira BioSciences$29.42-1.5%5 of 5 stars3.00$47.40 61.1%10High Trading Volume1.04%LBPHLongboard Pharmaceuticals$20.12-8.5%3 of 5 stars3.00$43.67 117.0%6Short Interest ↓Analyst Revision1.02%HRMYHarmony Biosciences$30.14-3.6%4 of 5 stars2.50$40.63 34.8%8Positive News0.98%COLLCollegium Pharmaceutical$31.50-16.8%3 of 5 stars2.20$39.00 23.8%5Analyst DowngradeGap DownHigh Trading Volume0.86%LQDALiquidia$12.06-3.4%2 of 5 stars2.60$21.00 74.1%5Upcoming Earnings0.80%AMLXAmylyx Pharmaceuticals$1.76-7.1%3 of 5 stars2.25$32.67 1,761.3%8Earnings ReportAnalyst Forecast0.77%SUPNSupernus Pharmaceuticals$28.96-3.5%4 of 5 stars3.00$41.00 41.6%1High Trading Volume0.75%AMRXAmneal Pharmaceuticals$6.66+2.9%2 of 5 stars3.00$8.25 23.9%4Short Interest ↓0.70%LGNDLigand Pharmaceuticals$87.28+1.3%5 of 5 stars3.00$116.33 33.3%3Earnings Report0.56%ANIPANI Pharmaceuticals$68.05+3.3%5 of 5 stars3.00$80.00 17.6%4Gap UpHigh Trading Volume0.51%PLRXPliant Therapeutics$13.814 of 5 stars3.00$45.67 230.7%10Analyst Revision0.48%RVNCRevance Therapeutics$3.32-22.6%4 of 5 stars2.50$11.75 253.9%8Analyst ForecastGap DownHigh Trading Volume0.40%EOLSEvolus$12.75-2.9%4 of 5 stars3.00$20.60 61.6%30.34%TBPHTheravance Biopharma$9.38-1.0%2 of 5 stars3.00$20.50 118.6%2News Coverage0.30%XERSXeris Biopharma$1.76-6.4%4 of 5 stars3.00$4.63 162.8%4Earnings ReportAnalyst Forecast0.28%OCULOcular Therapeutix$5.66-3.1%3 of 5 stars2.83$15.17 168.0%6Short Interest ↑Analyst Revision0.24%FULCFulcrum Therapeutics$7.47-0.4%2 of 5 stars2.83$13.17 76.3%6Short Interest ↑0.06%MRNSMarinus Pharmaceuticals$1.33-4.0%4 of 5 stars2.57$13.79 936.5%7Analyst Revision This page (NYSEARCA:PILL) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBill Clinton Backing Biden Replacement???The Freeport SocietyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
